Status:
COMPLETED
Effects of Sargassum Horneri Extract on Patients With Hypersensitivity
Lead Sponsor:
Pusan National University Yangsan Hospital
Conditions:
Skin Hypersensitivity
Eligibility:
All Genders
12-50 years
Phase:
NA
Brief Summary
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Sargassum Horneri Extract in patients with skin hypersensitivity for 12 weeks.
Detailed Description
Previous studies have indicated that Panax Ginseng C.A. Mey Extract may have the ability to improve liver function. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled ...
Eligibility Criteria
Inclusion
- Atopy by Hanifin \& Rajka diagnostic criteria
- SCORAD \< 40
Exclusion
- Abnormal liver or renal function (i.e., serum aminotransferase activity \> 3 times of upper limit of reference range and serum creatinine concentrations \> 1.2 mg/dL)
- Diabetes (diagnosed clinically or fasting glucose level \> 126 mg/dL)
- History of viral hepatitis or cancer
- Uncontrolled hypertension
- History of serious cardiac disease such as angina or myocardial infarction
- History of gastrectomy
- History of medication for psychiatric disease
- Administration of oriental medicine including herbs within the past 4 weeks
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03849378
Start Date
January 1 2019
End Date
February 28 2022
Last Update
April 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan National University Yangsan Hospital
Yangsan, Gyeungsangnam-do, South Korea, 50612